Respiratory Syncytial Virus (RSV)
Epidemiology
- Common in first few years of life (may cause tracheobronchitis/ pneumonia/ bronchiolitis)
- High-risk adults (most cases are self-limited but immunocompromised may develop pneumonia/ ARDS):
- Post-BMT: most commonly reported adult group
- Leukemics: especially im cases with severe chemo-induced myelosuppression
- Elderly:
- Institutionalized:
- Other immunocompromised:
Diagnosis
- Sputum GS/Cult+Sens:
- FOB:
- BAL: viral culture is positive/ ELISA or IF viral antigen tests are positive
- TBB: syncytial cells or viral cytoplasmic inclusions/ immunohisto-chemical stains with monoclonal Ab’s
- CXR/Chest CT Patterns
- Diffuse alveolar infiltrates:
Clinical Presentation
- Pneumonia (see [[Pneumonia]])
- Pleural Effusion (see [[Pleural Effusion-Exudate]])
- [[Acute Lung Injury-ARDS]]
Treatment
- Aerosolized Ribavirin + IVIG:
- No human clinical studies support this
- Animal studies support use of IVIG
- Infection control: contact precautions
Prognosis
- 83% mortality in leukemia-related cases
References